With an ultra high-tech pharmaceutical packaging lab currently under construction, Grand Valley State University this week became the newest member of a collaborative statewide network of advanced research and technological facilities known as the Core Technology Alliance.
Established in 2000, the CTA provides access to sophisticated and generally expensive technologies for researchers, biotech firms, and entrepreneurs in an effort to accelerate the expansion of the life sciences industry accross the state.
Grand Valley now is partnered with the Van Andel Institute in the construction of a modern pharmaceutical packaging lab geared for small firms, governement researchers, and educational institutions. The so-called Grand River Aseptic Pharmaceutical Packaging facility is scheduled to be completed this summer.
“This new [facility] represents yet another unique feature in the drug development pipeline the CTA has built throughout the State of Michigan,” said Dr. George Vande Woude, who serves as president and ceo of the CTA as well as director of research at the Van Andel Institute.
"Grand Valley is excited to be a member of the Core Technology Alliance,” said Thomas J. Haas, president of Grand Valley. “Our membership represents our strong commitment to economic development in West Michigan and in the rest of the state."
Grand Valley joins other prominent CTA members including Michigan State University, the University of Michigan, the Van Andel Research Institute, Wayne State University, and Western Michigan University.
Source: Joe Gavan, Van Andel Research Institute
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.